1 Introduction to Research & Analysis Reports |
|
1.1 Medical Inhaler Market Definition |
|
1.2 Market Segments |
|
| 1.2.1 Segment by Type | |
| 1.2.2 Segment by Application | |
1.3 China Medical Inhaler Market Overview |
|
1.4 Methodology & Sources of Information |
|
| 1.4.1 Research Methodology | |
| 1.4.2 Research Process | |
| 1.4.3 Base Year | |
2 China Medical Inhaler Overall Market Size |
|
2.1 China Medical Inhaler Market Size: 2021 VS 2027 |
|
2.2 China Medical Inhaler Revenue, Prospects & Forecasts: 2016-2027 |
|
2.3 China Medical Inhaler Sales: 2016-2027 |
|
3 Company Landscape |
|
3.1 Top Medical Inhaler Players in China Market |
|
3.2 Top China Medical Inhaler Companies Ranked by Revenue |
|
3.3 China Medical Inhaler Revenue by Companies |
|
3.4 China Medical Inhaler Sales by Companies |
|
3.5 China Medical Inhaler Price by Manufacturer (2016-2021) |
|
3.6 Top 3 and Top 5 Medical Inhaler Companies in China Market, by Revenue in 2020 |
|
3.7 Manufacturers Medical Inhaler Product Type |
|
3.8 Tier 1, Tier 2 and Tier 3 Medical Inhaler Players in China Market |
|
| 3.8.1 List of Tier 1 Medical Inhaler Companies in China | |
| 3.8.2 List of Tier 2 and Tier 3 Medical Inhaler Companies in China | |
4 Sights by Type |
|
4.1 Overview |
|
| 4.1.1 By Type - China Medical Inhaler Market Size Markets, 2021 & 2027 | |
| 4.1.2 Pressurised Metered Dose Inhaler (PMDI) | |
| 4.1.3 Dry Powder Inhaler (DPI) | |
| 4.1.4 Others | |
4.2 By Type - China Medical Inhaler Revenue & Forecasts |
|
| 4.2.1 By Type - China Medical Inhaler Revenue, 2016-2021 | |
| 4.2.2 By Type - China Medical Inhaler Revenue, 2022-2027 | |
| 全:文：http://www.qdlaimaiche.com/6/99/2021-2027-China-Medical-Inhaler-Market-Analysis-and-Trends-Report.html | |
| 4.2.3 By Type - China Medical Inhaler Revenue Market Share, 2016-2027 | |
4.3 By Type - China Medical Inhaler Sales & Forecasts |
|
| 4.3.1 By Type - China Medical Inhaler Sales, 2016-2021 | |
| 4.3.2 By Type - China Medical Inhaler Sales, 2022-2027 | |
| 4.3.3 By Type - China Medical Inhaler Sales Market Share, 2016-2027 | |
4.4 By Type - China Medical Inhaler Price (Manufacturers Selling Prices), 2016-2027 |
|
5 Sights by Application |
|
5.1 Overview |
|
| 5.1.1 By Application - China Medical Inhaler Market Size, 2021 & 2027 | |
| 5.1.2 Asthma | |
| 5.1.3 Chronic Obstructive Pulmonary Disease (COPD) | |
| 5.1.4 Allergic Rhinitis | |
5.2 By Application - China Medical Inhaler Revenue & Forecasts |
|
| 5.2.1 By Application - China Medical Inhaler Revenue, 2016-2021 | |
| 5.2.2 By Application - China Medical Inhaler Revenue, 2022-2027 | |
| 5.2.3 By Application - China Medical Inhaler Revenue Market Share, 2016-2027 | |
5.3 By Application - China Medical Inhaler Sales & Forecasts |
|
| 5.3.1 By Application - China Medical Inhaler Sales, 2016-2021 | |
| 5.3.2 By Application - China Medical Inhaler Sales, 2022-2027 | |
| 5.3.3 By Application - China Medical Inhaler Sales Market Share, 2016-2027 | |
5.4 By Application - China Medical Inhaler Price (Manufacturers Selling Prices), 2016-2027 |
|
6 Manufacturers & Brands Profiles |
|
6.1 GSK |
|
| 6.1.1 GSK Corporation Information | |
| 6.1.2 GSK Overview | |
| 6.1.3 GSK Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.1.4 GSK Medical Inhaler Product Description | |
| 6.1.5 GSK Recent Developments | |
6.2 AstraZeneca |
|
| 6.2.1 AstraZeneca Corporation Information | |
| 6.2.2 AstraZeneca Overview | |
| 6.2.3 AstraZeneca Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.2.4 AstraZeneca Medical Inhaler Product Description | |
| 6.2.5 AstraZeneca Recent Developments | |
6.3 Boehringer Ingelheim |
|
| 6.3.1 Boehringer Ingelheim Corporation Information | |
| 6.3.2 Boehringer Ingelheim Overview | |
| 6.3.3 Boehringer Ingelheim Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.3.4 Boehringer Ingelheim Medical Inhaler Product Description | |
| 6.3.5 Boehringer Ingelheim Recent Developments | |
6.4 Chiesi |
|
| 6.4.1 Chiesi Corporation Information | |
| 6.4.2 Chiesi Overview | |
| 6.4.3 Chiesi Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.4.4 Chiesi Medical Inhaler Product Description | |
| 6.4.5 Chiesi Recent Developments | |
6.5 Cipla |
|
| 6.5.1 Cipla Corporation Information | |
| 6.5.2 Cipla Overview | |
| 6.5.3 Cipla Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.5.4 Cipla Medical Inhaler Product Description | |
| 6.5.5 Cipla Recent Developments | |
6.6 3M |
|
| 6.6.1 3M Corporation Information | |
| 6.6.2 3M Overview | |
| 6.6.3 3M Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.6.4 3M Medical Inhaler Product Description | |
| 6.6.5 3M Recent Developments | |
6.7 Hovione |
|
| 6.7.1 Hovione Corporation Information | |
| 6.7.2 Hovione Overview | |
| 6.7.3 Hovione Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.7.4 Hovione Medical Inhaler Product Description | |
| 6.7.5 Hovione Recent Developments | |
6.8 Mannkind |
|
| 6.8.1 Mannkind Corporation Information | |
| 6.8.2 Mannkind Overview | |
| 6.8.3 Mannkind Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 2021-2027年中國(guó)醫(yī)用吸入器市場(chǎng)分析及趨勢(shì)報(bào)告 | |
| 6.8.4 Mannkind Medical Inhaler Product Description | |
| 6.8.5 Mannkind Recent Developments | |
6.9 Mylan |
|
| 6.9.1 Mylan Corporation Information | |
| 6.9.2 Mylan Overview | |
| 6.9.3 Mylan Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.9.4 Mylan Medical Inhaler Product Description | |
| 6.9.5 Mylan Recent Developments | |
6.10 Novartis |
|
| 6.10.1 Novartis Corporation Information | |
| 6.10.2 Novartis Overview | |
| 6.10.3 Novartis Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.10.4 Novartis Medical Inhaler Product Description | |
| 6.10.5 Novartis Recent Developments | |
6.11 Teva |
|
| 6.11.1 Teva Corporation Information | |
| 6.11.2 Teva Overview | |
| 6.11.3 Teva Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.11.4 Teva Medical Inhaler Product Description | |
| 6.11.5 Teva Recent Developments | |
6.12 Vectura |
|
| 6.12.1 Vectura Corporation Information | |
| 6.12.2 Vectura Overview | |
| 6.12.3 Vectura Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.12.4 Vectura Medical Inhaler Product Description | |
| 6.12.5 Vectura Recent Developments | |
6.13 Adherium |
|
| 6.13.1 Adherium Corporation Information | |
| 6.13.2 Adherium Overview | |
| 6.13.3 Adherium Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.13.4 Adherium Medical Inhaler Product Description | |
| 6.13.5 Adherium Recent Developments | |
6.14 Cohero Health |
|
| 6.14.1 Cohero Health Corporation Information | |
| 6.14.2 Cohero Health Overview | |
| 6.14.3 Cohero Health Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.14.4 Cohero Health Medical Inhaler Product Description | |
| 6.14.5 Cohero Health Recent Developments | |
6.15 Opko |
|
| 6.15.1 Opko Corporation Information | |
| 6.15.2 Opko Overview | |
| 6.15.3 Opko Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.15.4 Opko Medical Inhaler Product Description | |
| 6.15.5 Opko Recent Developments | |
6.16 ResMed |
|
| 6.16.1 ResMed Corporation Information | |
| 6.16.2 ResMed Overview | |
| 6.16.3 ResMed Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.16.4 ResMed Medical Inhaler Product Description | |
| 6.16.5 ResMed Recent Developments | |
6.17 Beximco Pharma |
|
| 6.17.1 Beximco Pharma Corporation Information | |
| 6.17.2 Beximco Pharma Overview | |
| 6.17.3 Beximco Pharma Medical Inhaler Sales and Revenue in China Market (2016-2021) | |
| 6.17.4 Beximco Pharma Medical Inhaler Product Description | |
| 6.17.5 Beximco Pharma Recent Developments | |
7 China Medical Inhaler Production Capacity, Analysis |
|
7.1 China Medical Inhaler Production Capacity, 2016-2027 |
|
7.2 Medical Inhaler Production Capacity of Key Manufacturers in China Market |
|
8 Key Market Trends, Opportunity, Drivers and Restraints |
|
8.1 Market Opportunities & Trends |
|
8.2 Market Drivers |
|
8.3 Market Restraints |
|
9 Medical Inhaler Supply Chain Analysis |
|
9.1 Medical Inhaler Industry Value Chain |
|
| 2021-2027年中國(guó)醫(yī)用吸入器市場(chǎng)分析及趨勢(shì)報(bào)告 | |
9.2 Medical Inhaler Upstream Market |
|
9.3 Medical Inhaler Downstream and Clients |
|
9.4 Marketing Channels Analysis |
|
| 9.4.1 Marketing Channels | |
| 9.4.2 Medical Inhaler Distributors and Sales Agents in China Market | |
10 Conclusion |
|
11 Appendix |
|
11.1 Note |
|
11.2 Examples of Clients |
|
11.3 Author Details |
|
11.4 Disclaimer |
|
| List of Tables | |
| Table 1. Key Players of Medical Inhaler in China Market | |
| Table 2. Top Medical Inhaler Players in China Market, Ranking by Revenue (2019) | |
| Table 3. China Medical Inhaler Revenue by Companies, (US$, Mn), 2016-2021 | |
| Table 4. China Medical Inhaler Revenue Share by Companies, 2016-2021 | |
| Table 5. China Medical Inhaler Sales by Companies, (K Units), 2016-2021 | |
| Table 6. China Medical Inhaler Sales Share by Companies, 2016-2021 | |
| Table 7. Key Manufacturers Medical Inhaler Price (2016-2021) & (US$/Unit) | |
| Table 8. Manufacturers Medical Inhaler Product Type | |
| Table 9. List of Tier 1 Medical Inhaler Companies, Revenue (US$, Mn) in 2020 and Market Share | |
| Table 10. List of Tier 2 and Tier 3 Medical Inhaler Companies, Revenue (US$, Mn) in 2020 and Market Share | |
| Table 11. Major Manufacturers of Pressurised Metered Dose Inhaler (PMDI) | |
| Table 12. Major Manufacturers of Dry Powder Inhaler (DPI) | |
| Table 13. By Type – China Medical Inhaler Revenue, (US$, Mn), 2021 & 2027 | |
| Table 14. By Type - China Medical Inhaler Revenue (US$, Mn), 2016-2021 | |
| Table 15. By Type - China Medical Inhaler Revenue (US$, Mn), 2022-2027 | |
| Table 16. By Type - China Medical Inhaler Sales (K Units), 2016-2021 | |
| Table 17. By Type - China Medical Inhaler Sales (K Units), 2022-2027 | |
| Table 18. By Application – China Medical Inhaler Revenue, (US$, Mn), 2021 VS 2027 | |
| Table 19. By Application - China Medical Inhaler Revenue (US$, Mn), 2016-2021 | |
| Table 20. By Application - China Medical Inhaler Revenue (US$, Mn), 2022-2027 | |
| Table 21. By Application - China Medical Inhaler Sales (K Units), 2016-2021 | |
| Table 22. By Application - China Medical Inhaler Sales (K Units), 2022-2027 | |
| Table 23. GSK Corporation Information | |
| Table 24. GSK Description and Major Businesses | |
| Table 25. GSK Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 26. GSK Medical Inhaler Product | |
| Table 27. GSK Recent Developments | |
| Table 28. AstraZeneca Corporation Information | |
| Table 29. AstraZeneca Description and Major Businesses | |
| Table 30. AstraZeneca Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 31. AstraZeneca Medical Inhaler Product | |
| Table 32. AstraZeneca Recent Developments | |
| Table 33. Boehringer Ingelheim Corporation Information | |
| Table 34. Boehringer Ingelheim Description and Major Businesses | |
| Table 35. Boehringer Ingelheim Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 36. Boehringer Ingelheim Medical Inhaler Product | |
| Table 37. Boehringer Ingelheim Recent Developments | |
| Table 38. Chiesi Corporation Information | |
| Table 39. Chiesi Description and Major Businesses | |
| Table 40. Chiesi Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 41. Chiesi Medical Inhaler Product | |
| Table 42. Chiesi Recent Developments | |
| Table 43. Cipla Corporation Information | |
| Table 44. Cipla Description and Major Businesses | |
| Table 45. Cipla Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 46. Cipla Medical Inhaler Product | |
| Table 47. Cipla Recent Developments | |
| Table 48. 3M Corporation Information | |
| Table 49. 3M Description and Major Businesses | |
| Table 50. 3M Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 51. 3M Medical Inhaler Product | |
| Table 52. 3M Recent Developments | |
| Table 53. Hovione Corporation Information | |
| Table 54. Hovione Description and Major Businesses | |
| Table 55. Hovione Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| 2021-2027 Nian Zhong Guo Yi Yong Xi Ru Qi Shi Chang FenXi Ji Qu Shi Bao Gao | |
| Table 56. Hovione Medical Inhaler Product | |
| Table 57. Hovione Recent Developments | |
| Table 58. Mannkind Corporation Information | |
| Table 59. Mannkind Description and Major Businesses | |
| Table 60. Mannkind Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 61. Mannkind Medical Inhaler Product | |
| Table 62. Mannkind Recent Developments | |
| Table 63. Mylan Corporation Information | |
| Table 64. Mylan Description and Major Businesses | |
| Table 65. Mylan Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 66. Mylan Medical Inhaler Product | |
| Table 67. Mylan Recent Developments | |
| Table 68. Novartis Corporation Information | |
| Table 69. Novartis Description and Major Businesses | |
| Table 70. Novartis Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 71. Novartis Medical Inhaler Product | |
| Table 72. Novartis Recent Developments | |
| Table 73. Teva Corporation Information | |
| Table 74. Teva Description and Major Businesses | |
| Table 75. Teva Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 76. Teva Medical Inhaler Product | |
| Table 77. Teva Recent Developments | |
| Table 78. Vectura Corporation Information | |
| Table 79. Vectura Description and Major Businesses | |
| Table 80. Vectura Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 81. Vectura Medical Inhaler Product | |
| Table 82. Vectura Recent Developments | |
| Table 83. Adherium Corporation Information | |
| Table 84. Adherium Description and Major Businesses | |
| Table 85. Adherium Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 86. Adherium Medical Inhaler Product | |
| Table 87. Adherium Recent Developments | |
| Table 88. Cohero Health Corporation Information | |
| Table 89. Cohero Health Description and Major Businesses | |
| Table 90. Cohero Health Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 91. Cohero Health Medical Inhaler Product | |
| Table 92. Cohero Health Recent Developments | |
| Table 93. Opko Corporation Information | |
| Table 94. Opko Description and Major Businesses | |
| Table 95. Opko Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 96. Opko Medical Inhaler Product | |
| Table 97. Opko Recent Developments | |
| Table 98. ResMed Corporation Information | |
| Table 99. ResMed Description and Major Businesses | |
| Table 100. ResMed Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 101. ResMed Medical Inhaler Product | |
| Table 102. ResMed Recent Developments | |
| Table 103. Beximco Pharma Corporation Information | |
| Table 104. Beximco Pharma Description and Major Businesses | |
| Table 105. Beximco Pharma Medical Inhaler Sales (K Units), Revenue (US$, Mn) and Gross Margin (US$/Unit) (2016-2021) | |
| Table 106. Beximco Pharma Medical Inhaler Product | |
| Table 107. Beximco Pharma Recent Developments | |
| Table 108. Medical Inhaler Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units) | |
| Table 109. China Medical Inhaler Capacity Market Share of Key Manufacturers, 2019-2021 | |
| Table 110. Medical Inhaler Market Opportunities & Trends in China Market | |
| Table 111. Medical Inhaler Market Drivers in China Market | |
| Table 112. Medical Inhaler Market Restraints in China Market | |
| Table 113. Medical Inhaler Raw Materials | |
| Table 114. Medical Inhaler Raw Materials Suppliers in China Market | |
| Table 115. Typical Medical Inhaler Downstream | |
| Table 116. Medical Inhaler Downstream Clients in China Market | |
| Table 117. Medical Inhaler Distributors and Sales Agents in China Market | |
| List of Figures | |
| Figure 1. Medical Inhaler Product Picture | |
| Figure 2. Medical Inhaler Segment by Type | |
| Figure 3. Medical Inhaler Segment by Application | |
| Figure 4. China Medical Inhaler Market Overview: 2020 | |
| 2021-2027中國(guó)醫(yī)療吸入器市場(chǎng)分析と動(dòng)向レポート | |
| Figure 5. China Medical Inhaler Market Size: 2021 VS 2027 (US$, Mn) | |
| Figure 6. China Medical Inhaler Revenue, 2016-2027 (US$, Mn) | |
| Figure 7. Medical Inhaler Sales in China Market: 2016-2027 (K Units) | |
| Figure 8. The Top 3 and 5 Players Market Share by Medical Inhaler Revenue in 2020 | |
| Figure 9. Pressurised Metered Dose Inhaler (PMDI) Product Picture | |
| Figure 10. Dry Powder Inhaler (DPI) Product Picture | |
| Figure 11. Others Product Picture | |
| Figure 12. By Type - China Medical Inhaler Sales Market Share, 2016-2027 | |
| Figure 13. By Type - China Medical Inhaler Revenue Market Share, 2016-2027 | |
| Figure 14. By Type - China Medical Inhaler Price (US$/Unit), 2016-2027 | |
| Figure 15. Asthma | |
| Figure 16. Chronic Obstructive Pulmonary Disease (COPD) | |
| Figure 17. Allergic Rhinitis | |
| Figure 18. By Application - China Medical Inhaler Sales Market Share, 2016-2027 | |
| Figure 19. By Application - China Medical Inhaler Revenue Market Share, 2016-2027 | |
| Figure 20. By Application - China Medical Inhaler Price (US$/Unit), 2016-2027 | |
| Figure 21. GSK Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 22. AstraZeneca Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 23. Boehringer Ingelheim Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 24. Chiesi Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 25. Cipla Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 26. 3M Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 27. Hovione Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 28. Mannkind Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 29. Mylan Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 30. Novartis Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 31. Teva Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 32. Vectura Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 33. Adherium Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 34. Cohero Health Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 35. Opko Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 36. ResMed Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 37. Beximco Pharma Medical Inhaler Revenue Year Over Year Growth (US$, Mn) & (2016-2021) | |
| Figure 38. China Medical Inhaler Production Capacity (K Units), 2016-2027 | |
| Figure 39. Medical Inhaler Industry Value Chain | |
| Figure 40. Marketing Channels | |
…
如需購(gòu)買(mǎi)《2021-2027 China Medical Inhaler Market Analysis and Trends Report》，編號(hào)：3179996
請(qǐng)您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購(gòu)】 ┊ 下載《訂購(gòu)協(xié)議》 ┊ 了解“訂購(gòu)流程”
請(qǐng)您致電：400 612 8668、010-6618 1099、66182099、66183099
或Email至：KF@Cir.cn 【網(wǎng)上訂購(gòu)】 ┊ 下載《訂購(gòu)協(xié)議》 ┊ 了解“訂購(gòu)流程”
京公網(wǎng)安備 11010802027365號(hào)